Antigen-binding molecules specifically binding to tfr1 and medical uses thereof

TW202641858APending Publication Date: 2026-10-16JIANGSU HENGRUI MEDICINE CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114151486
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-06-06
Filing Date
2025-12-26
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080821_001
    Figure TWG2TA001080821_001
  • Figure TWG2TA001080821_002
    Figure TWG2TA001080821_002
  • Figure TWG2TA001080821_003
    Figure TWG2TA001080821_003
Patent Text Reader

Abstract

The present disclosure relates to antigen-binding molecules specifically binding to TfR1 and medical uses thereof. Specifically, the present disclosure relates to the use of antigen-binding molecules specifically binding to TfR1 in the preparation of medicaments for preventing or treating neurological disorders.
Need to check novelty before this filing date? Find Prior Art